What this study is
The purpose of this clinical trial is to evaluate an evidence-based intervention, Health Impact 360, toward the promotion of cardiovascular health (CVH), including physical, mental, and social health outcomes, among adults living in marginalized communities.
Study hypotheses include:
- Participants in the Health Impact 360 intervention arm will have better CVH (i.e., a higher overall LE8 score) at the 16-week endpoint compared to the control.
- Participants in the Health Impact 360 intervention arm will report better mental health (i.e., a lower perceived stress score) at the 16-week endpoint compared to the control.
- Participants in the Health Impact 360 intervention arm will report better social support and well-being (i.e., higher emotional support and instrumental support scores and reduced social isolation) at the 16-week endpoint compared to control.
- Participants with greater intervention engagement (e.g., better session attendance) will experience greater intervention impacts across all primary and secondary outcomes relative to the minimally engaged peers.
Researchers will compare outcomes among intervention participants to outcomes among delayed intervention control participants who will be invited to participate in Health Impact 360 once all endpoint measures are collected.
Participants will:
- Engage in group-based programming twice per week for 8 weeks
- Engage in group-based programming once per week for 8 weeks
- Participate in survey-based and biometric data collection at two timepoints: baseline and 16-week endpoint
- Self-monitor their physical activity via a study-provided pedometer
What's being tested
- Health Impact 360
Intervention · BEHAVIORAL
Participants will be assigned to a team and teams will meet 1-2 times per week for sessions at a local community organization. Sessions will be up to 2 hours long and will include two parts: (1) 30-60 minutes of activities related to physical, mental, social, financial, and community health, and (2) 60-75 minutes of group physical activity (walking), including stretches to warm up and cool down.
- Usual care - Wait list control
Intervention · OTHER
Participants will be on this for approximately 16 weeks and be asked to complete data collection information at baseline and 16 weeks.
Study details
- Sponsor
- University of Michigan
- Conditions
- Health Promotion · Cardiovascular Health
- Enrolling
- 328 people
- Starts
- 2025-06-20
- Est. completion
- 2026-12
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- English or Spanish speaking
- Able to participate in group-based programming
You can't join if
- All pregnant persons to prevent pregnancy-related biometric changes from biasing outcome analyses
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (7)
4 openHasselbringe Senior Center
Flint, Michigan, United States
- Tarnesa Martin · Contact313-583-7088healthimpact360@umich.edu
RecruitingSpirit of Victory
Flint, Michigan, United States
- Tarnesa Martin · Contact313-583-7088healthimpact360@umich.edu
RecruitingFlint Development Center
Flint, Michigan, United States
- Latressa Gordon · Contact313-583-7088healthimpact360@umich.edu
RecruitingRL Jones Community Center
Flint, Michigan, United States
- Latressa Gordon · Contact313-583-7088healthimpact360@umich.edu
RecruitingCommunity Health and Social Service Centers (CHASS)
Detroit, Michigan, United States
CompletedEastside Community Network (ECN)
Detroit, Michigan, United States
CompletedDetroit Hispanic Development Corporation (DHDC)
Detroit, Michigan, United States
Completed
Study team
Sponsor
University of Michigan
Study ID HUM00256551
Principal investigator
Jennifer Garner, PhD, RD
University of Michigan
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.